目的探討血管生成與原發(fā)性膽囊癌臨床病理特征和預后的關(guān)系。方法對42例原發(fā)性膽囊癌手術(shù)切除的腫瘤標本行免疫組織化學染色(SABC法),觀察腫瘤內(nèi)微血管計數(shù)(MVC)和血管內(nèi)皮生長因子(VEGF)的表達。結(jié)果膽囊組織中MVC平均值為(70.4±20.7)個,VEGF表達陽性率為69.0%。MVC在細胞學分級為Ⅰ、Ⅱ級組中平均值為(57.9±15.4)個,在Ⅲ、Ⅳ級組中平均值為(88.8±11.5)個,兩組相比較差異有顯著性意義(P<0.001); 在Nevin Ⅰ、Ⅱ、Ⅲ期病例組MVC平均值為(45.0±17.0)個,Ⅳ、Ⅴ期組平均值為(77.2±16.0)個,兩組相比較差異有顯著性意義(P<0.001)。VEGF表達陽性率與腫瘤細胞分級及腫瘤分期呈等級相關(guān),分化差、分期晚者VEGF表達顯著增高。VEGF的表達與MVC值呈顯著正相關(guān),MVC值高者或VEGF表達陽性者,3年生存率明顯降低。結(jié)論膽囊癌中VEGF的分泌增多可導致微血管數(shù)目增加,促進了病變進展和轉(zhuǎn)移。血管生成可作為判斷膽囊癌預后的一項有效指標。
引用本文: 楊毅軍,劉建民,石景森. 原發(fā)性膽囊癌組織中血管生成活性檢測的臨床意義. 中國普外基礎(chǔ)與臨床雜志, 2002, 9(5): 345-347. doi: 復制
1. | Hanahan D,F(xiàn)olkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J]. Cell,1996; 86(3)∶353. |
2. | Heimann R,F(xiàn)erguson D,Powers C,et al. Angiogenesis as a predictor of longterm survival for patients with nodenegative breast cancer [J]. J Natl Cancer Inst,1996; 88(23)∶1764. |
3. | Pavlopoulos PM,Konstantinidou AE,Agapitos E,et al. A morphometric study of neovascularization in colorectal carcinoma [J]. Cancer, 1998; 83(10)∶2067. |
4. | 楊毅軍,石景森. 血管內(nèi)皮生長因子與腫瘤血管生成 [J]. 中國普外基礎(chǔ)與臨床雜志, 2001; 8(3)∶205. |
5. | 白濤,郭仁宣,王浩. 血管生成與膽囊癌發(fā)展和預后的關(guān)系 [J]. 中國普外基礎(chǔ)與臨床雜志, 2001; 8(2)∶101. |
6. | Samoto K,Ikezaki K,Ono M,et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors [J]. Cancer Res,1995; 55(5)∶1189. |
7. | Okita S,Kondoh S,Shiraishi K,et al. Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer [J]. Int J Oncol,1998; 12(5)∶1013. |
8. | Benoist S,Panis Y,F(xiàn)agniez PL,et al. Longterm results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research [J]. Am J Surg,1998; 175(2)∶118. |
9. | McNamara DA,Harmey JH,Walsh TN,et al. Significance of angiogenesis in cancer therapy [J]. Br J Surg,1998; 85(8)∶1044. |
- 1. Hanahan D,F(xiàn)olkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J]. Cell,1996; 86(3)∶353.
- 2. Heimann R,F(xiàn)erguson D,Powers C,et al. Angiogenesis as a predictor of longterm survival for patients with nodenegative breast cancer [J]. J Natl Cancer Inst,1996; 88(23)∶1764.
- 3. Pavlopoulos PM,Konstantinidou AE,Agapitos E,et al. A morphometric study of neovascularization in colorectal carcinoma [J]. Cancer, 1998; 83(10)∶2067.
- 4. 楊毅軍,石景森. 血管內(nèi)皮生長因子與腫瘤血管生成 [J]. 中國普外基礎(chǔ)與臨床雜志, 2001; 8(3)∶205.
- 5. 白濤,郭仁宣,王浩. 血管生成與膽囊癌發(fā)展和預后的關(guān)系 [J]. 中國普外基礎(chǔ)與臨床雜志, 2001; 8(2)∶101.
- 6. Samoto K,Ikezaki K,Ono M,et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors [J]. Cancer Res,1995; 55(5)∶1189.
- 7. Okita S,Kondoh S,Shiraishi K,et al. Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer [J]. Int J Oncol,1998; 12(5)∶1013.
- 8. Benoist S,Panis Y,F(xiàn)agniez PL,et al. Longterm results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research [J]. Am J Surg,1998; 175(2)∶118.
- 9. McNamara DA,Harmey JH,Walsh TN,et al. Significance of angiogenesis in cancer therapy [J]. Br J Surg,1998; 85(8)∶1044.